This paper is only available as a PDF. To read, Please Download here.
A procedure is presented for purifying antithrombin-heparin cofactor from human plasma. The final product is homogeneous as judged by disc gel electrophoresis, sodium dodecyl sulfate gel electrophoresis, and immunoelectrophoresis. The final yield averages 12%. A specific antibody directed against pure inhibitor preparations precipitates virtually all of both antithrombin and heparin cofactor activity from defibrinated plasma. The purification, the immunoprecipitation, and other data, indicate that both activities are properties of a single molecular species.
The inhibitor and thrombin form a 1:1 stoichiometric complex which cannot be dissociated with denaturing and reducing agents. Addition of heparin, a widely used anticoagulant which specifically accelerates the action of our inhibitor, increases the rate of formation of this complex without altering its stoichiometry or its dissociability. Interaction of thrombin with antithrombin-heparin cofactor requires the presence of the active center serine of the enzyme and arginine residue(s) on the inhibitor, since chemical modification of either of these critical residues inhibits complex formation both in the presence and absence of heparin. We suggest that, in analogous fashion to trypsin-trypsin inhibitor systems, a specific interaction occurs between the active center serine of thrombin and a unique arginine-x reactive site on the antithrombin-heparin cofactor.
Furthermore, lysyl residues of the inhibitor probably serve as a binding site for heparin, since chemical modification of these residues virtually eliminates heparin cofactor activity with only minimal reduction of antithrombin activity. We postulate that heparin binds to the inhibitor and causes a conformational change which results in a more favorable exposure of the arginine reactive site, allowing a rapid interaction with thrombin.
REFERENCES
- Arch. Physiol. Norm. Pathol. 1895; 7: 45-53
- The Chemistry of Blood Coagulation. Charles C Thomas, Springfield, Illinois1968
- Harvey Led. 1916; 2: 272-323
- Amer. J. Physiol. 1954; 176: 97-103
- Amer. J. Physiol. 1916; 41: 250-257
- Amer. J. Physiol. 1939; 125: 683-687
- Amer. J. Physiol. 1956; 184: 627-638
- Circ. lies. 1955; 3: 397-402
- Scand. J. Clin. Lab. Invest. 1968; 21: 89-91
- Brit. J. Haematol. 1970; 19: 283-305
- Can. J. Biochem. 1964; 42: 359-364
- J. Biol. Chem. 1971; 246: 3694-3702
- J. Biol. Chem. 1965; 240: 2817-2820
- Thromb. Diath. Haemorrh. 1966; 16: 469-490
- Amer. J. Physiol. 1948; 152: 567-576
- J. Amer. Med. Assoc. 1938; 110: 1658-1662
- J. Biol. Chem. 1970; 245: 5049-5056
- Nature. 1967; 215: 1491-1492
- Methods Enzymol. 1970; 19: 924-932
- Biochem. Biophys. Res. Commun. 1971; 43: 524-529
- Biochem. J. 1971; 124: 677-683
- Bio chemistry. 1965; 4: 2302-2308
- J. Biol. Chem. 1951; 193: 265-275
- Academic Press, New York1962: 202-205 Fluorescence Assays in Biology and Medicine.
- Ann. N. Y. Acad. Sci. 1964; 121: 404-427
- J. Biol. Chem. 1969; 244: 4406-4412
- Thromb. Diath. Haemorrh. 1960; 4: 56-70
- Scand. J. Clin. Lab. Invest. 1967; 19: 190-195
- Thromb. Diath. Haemorrh. 1972; 27: 183-195
- Ini. Arch. Allergy Appl. Immunol. 1955; 7: 103-110
- Progress in Allergy. 5. S. Karger, Basel1958: 1-78
- J. Lab. Clin. Med. 1972; 79: 673-678
- Nature. 1960; 188: 156-157
- Statistical Analy sis in Chemistry and the Chemical Industry. J. Wiley and Sons, New York1954
- Arch. Sci. Physiol. 1956; 10: 129-142
- Acta Chem. Scand. 1966; 20: 820-834
- Biochemistry. 1968; 7: 2886-2892
- Scand. J. Hematol. 1970; 7: 10-17
- J. Biol. Chem. 1971; 246: 3712-3719
- J. Amer. Chem, . Soc. 1958; 80: 1263-1264
- J. Biol. Chem. 1953; 205: 535-551
- J. Biol. Chem. 1967; 242: 771-773
- Biochem. Biophys. Res. Commun. 1968; 31: 66-76
- Biochemistry. 1968; 7: 2879-2885
- Nature. 1967; 215: 1445-1448
- J. Biol Chem. 1971; 246: 939-945
- J. Biol. Chem. 1972; 247: 2704-2710
- J. Biol. Chem. 1972; 247: 5580-5586
- Biochemis try. 1970; 9: 166-170
- J. Biol. Chem. 1971; 246: 3703-3711
- Eur. J. Biochem. 1971; 18: 351-360
- Z. Physiol. Chem. 1968; 349: 1645-1656
- Nature New Biol. 1971; 231: 229-232
- J. Biol. Chem. 1971; 246: 755-7560
Article info
Publication history
Published online: September 25, 1973
Received:
February 5,
1972
Identification
Copyright
© 1973 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.
User license
Creative Commons Attribution (CC BY 4.0) | How you can reuse
Elsevier's open access license policy

Creative Commons Attribution (CC BY 4.0)
Permitted
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article
- Reuse portions or extracts from the article in other works
- Sell or re-use for commercial purposes
Elsevier's open access license policy